Cord Blood Stem Cell Act of 2003

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

Monitored the following: HR 801, the “Cloning Prohibition Act of 2003,” S.245, “Human Cloning Prohibition Act of 2003,” S.303, the “Human Cloning Ban and Stem Cell Research Protection Act of 2003,” HR 534, the “Human Cloning Prohibition Act of 2003,” HR 916, “Human Cloning Research Prohibition Act,” HR 2852, the “Cord Blood Stem Cell Act of 2003.” S.415, “Consumer Involvement in Breast Cancer Research Act,” S.314, “Foundation for the National Institutes of Health Improvement Act,” S.1717, “Cord Blood Stem Cell Act of 2003,” working with the Coalition for the Advancement of Medical research to track such issues.

Client expense: $380,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

Monitored HR 801, the "Cloning Prohibition Act of 2003," S.245, "Human Cloning Prohibition Act of 2003," S. 303, the "Human Cloning Ban and Stem Cell Research Protection Act of 2003," HR 534, the "Human Cloning Prohibition Act of 2003," HR 916, "Human Cloning Research Prohibition Act," and HR 2852, the "Stem Cell Act of 2003." Also, S.415, "Consumer Involvement in Breast Cancer Research Act," and S.314, "Foundation for the National Institutes of Health Improvement Act."

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE